Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Ehud Arbit"'
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e59524 (2013)
The unpredictable behavior of uncontrolled type 1 diabetes often involves frequent swings in blood glucose levels that impact maintenance of a daily routine. An intensified insulin regimen is often unsuccessful, while other therapeutic options, such
Externí odkaz:
https://doaj.org/article/2b9c4df5fb5e4c30a56d4ec4fdadea90
Autor:
Ariel Rothner, Yoseph Caraco, Michal Gershinsky, Ehud Arbit, Nariman Saba Khazen, Gregory Burshtein, Phillip Schwartz, Miriam Blum, Sofia Ish-Shalom, William D. Fraser, Auryan Szalat, Jonathan Tang, Arthur Raskin, Hillel Galitzer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffa736f07297d9eabc02ced82c27c8b
https://doi.org/10.1002/jbmr.4274/v3/response1
https://doi.org/10.1002/jbmr.4274/v3/response1
Autor:
Arthur Raskin, Miriam Blum, Ariel Rothner, Yoseph Caraco, William D. Fraser, Gregory Burshtein, Michal Gershinsky, Nariman Saba Khazen, Ehud Arbit, Hillel Galitzer, Auryan Szalat, Jonathan Tang, Phillip Schwartz, Sofia Ish-Shalom
Publikováno v:
Journal of Bone and Mineral Research
The standard treatment of primary hypoparathyroidism (hypoPT) with oral calcium supplementation and calcitriol (or an analog), intended to control hypocalcemia and hyperphosphatemia and avoid hypercalciuria, remains challenging for both patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811e32c76423e340fc74bc7dcafc5ea3
https://pubmed.ncbi.nlm.nih.gov/33666947
https://pubmed.ncbi.nlm.nih.gov/33666947
Autor:
Ehud Arbit, Miriam Kidron
Publikováno v:
Journal of Diabetes Science and Technology. 11:825-832
Insulin remains indispensable to the treatment of diabetes, but its availability in injectable form only has hampered its timely and broader use. The development of an oral insulin remains an ultimate goal to both enhance ease of use, and to provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca242cf699a4d4048e8903444c5bec5
https://doi.org/10.1177/1932296817691303
https://doi.org/10.1177/1932296817691303
Autor:
Claus Christiansen, Morten A. Karsdal, Nozer Mehta, B.J. Riis, Ehud Arbit, Kim Henriksen, William Stern
Publikováno v:
British Journal of Clinical Pharmacology. 79:720-732
The oral delivery of peptides and proteins has been hampered by an array of obstacles. However, several promising novel oral delivery systems have been developed. This paper reviews the most advanced oral formulation technologies, and highlights key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2567618a341fe3b86c3e87be085871b0
https://doi.org/10.1111/bcp.12557
https://doi.org/10.1111/bcp.12557
Publikováno v:
Journal of Diabetes Science and Technology. 4:1516-1523
Background: Glucagon-like peptide-1 (GLP-1) and its analogs are associated with a gamut of physiological processes, including induction of insulin release, support of normoglycemia, β-cell function preservation, improved lipid profiles, and increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe0c23ffdcc40c7d6e56c404f33c565
https://doi.org/10.1177/193229681000400629
https://doi.org/10.1177/193229681000400629
Autor:
Miriam Kidron, Ehud Arbit
Publikováno v:
Journal of Diabetes Science and Technology. 3:562-567
Insulin remains the most effective and durable hypoglycemic agent for the treatment of diabetes. The addition of an effective oral insulin dosage form to the antidiabetes armamentarium may have significant benefits in terms of fostering compliance an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749dffe1066ffa513eb61fa8e1a8093c
https://doi.org/10.1177/193229680900300322
https://doi.org/10.1177/193229680900300322
Autor:
Ehud Arbit
Publikováno v:
Diabetes Technology & Therapeutics. 6:510-517
Insulin remains the most effective and durable drug in the armamentarium for the treatment of advanced-stage diabetes. Nevertheless, clinical studies have shown that even on insulin treatment, a significant percentage of patients fail to attain lasti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8b61d2613e98630f34542ee68a009d
https://doi.org/10.1089/1520915041705929
https://doi.org/10.1089/1520915041705929
Autor:
Morten Asser, Karsdal, Bente Juul, Riis, Nozer, Mehta, William, Stern, Ehud, Arbit, Claus, Christiansen, Kim, Henriksen
Publikováno v:
British journal of clinical pharmacology. 79(5)
The oral delivery of peptides and proteins has been hampered by an array of obstacles. However, several promising novel oral delivery systems have been developed. This paper reviews the most advanced oral formulation technologies, and highlights key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffe2de4400999c121caee8139648d7eb
https://pubmed.ncbi.nlm.nih.gov/25408230
https://pubmed.ncbi.nlm.nih.gov/25408230
Autor:
Ronald J. Scheff, Susan C. Pannullo, Dmitriy Kravchinskiy, Charles G. Zaroulis, Ehud Arbit, Roberta L. Hayes, Marcel Odaimi
Publikováno v:
Critical Reviews in Oncology/Hematology. 39:31-42
The median survival for adults with recurrent primary malignant gliomas is 56 weeks following surgery, radiation, and chemotherapy. Generally, reoperation can extend the median survival an additional 26–32 weeks. We have developed an aggressive tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a45f6138dfa27a6091cb26c733166b0
https://doi.org/10.1016/s1040-8428(01)00122-6
https://doi.org/10.1016/s1040-8428(01)00122-6